Safety and preliminary efficacyof Meldonium in metastatic renal cell carcinoma (mRCC) patients with treatment-related fatigue: Phase 1/2 study results

Authors
Category Primary study
ConferenceEuropean Society For Medical Oncology Congress, ESMO 2025
Year 2025
This article has no abstract
Epistemonikos ID: 743b927411f0f8d9f6f023f0dcc6d443a212b9b8
First added on: May 16, 2026